Found 40 matching trials
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
PHASE4The main objective of this study is to evaluate the efficacy of SZC as comp...
Comparison of Potassium Binders in the ER
PHASE4Compare efficacy of 3 oral potassium binders (cation exchange resins) on lo...
Location
University of California, Irvine Medical Center
Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.
PHASE3Subjects who completed the Double-blind Randomized Maintenance Phase (DBRMP...
Location
Multiple Locations
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
PHASE2This is an international, multicentre, parallel-group, randomised, double-b...
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
PHASE3Heart failure (HF) and Chronic Kidney Disease (CKD) patients are frequently...
Location
Hospital Universitario Fundación Alcorcón
Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia
PHASE4Prescribing Sodium zirconium cyclosilicate (SZC) with enhanced nutritional ...
Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
PHASE4This is an open-label, randomised study in participants with chronic kidney...
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
PHASE3To evaluate the efficacy of two different doses (5 and 10 g) of ZS orally a...
Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects
PHASE1This study will be an open-label, randomised sequence, 2-period, 2-cohort, ...
Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.
PHASE3It is hypothesized that ZS is more effective than placebo control (alternat...
Location
Multiple Locations